Logo image of ACO-X.CA

ATCO LTD -CLASS I (ACO-X.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-X - CA0467894006 - Common Stock

53.74 CAD
-0.76 (-1.39%)
Last: 12/4/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, ACO-X scores 5 out of 10 in our fundamental rating. ACO-X was compared to 20 industry peers in the Multi-Utilities industry. ACO-X has an average financial health and profitability rating. ACO-X has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ACO-X was profitable.
In the past year ACO-X had a positive cash flow from operations.
In the past 5 years ACO-X has always been profitable.
In the past 5 years ACO-X always reported a positive cash flow from operatings.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

ACO-X has a Return On Assets (1.55%) which is comparable to the rest of the industry.
ACO-X's Return On Equity of 9.08% is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
ACO-X's Return On Invested Capital of 3.73% is on the low side compared to the rest of the industry. ACO-X is outperformed by 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACO-X is in line with the industry average of 3.84%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 8.38%, ACO-X perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
ACO-X's Profit Margin has declined in the last couple of years.
ACO-X's Operating Margin of 24.56% is in line compared to the rest of the industry. ACO-X outperforms 45.00% of its industry peers.
ACO-X's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 74.90%, ACO-X is in line with its industry, outperforming 45.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ACO-X has remained more or less at the same level.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACO-X is destroying value.
ACO-X has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACO-X has less shares outstanding
Compared to 1 year ago, ACO-X has a worse debt to assets ratio.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that ACO-X is in the distress zone and has some risk of bankruptcy.
ACO-X's Altman-Z score of 0.77 is amongst the best of the industry. ACO-X outperforms 85.00% of its industry peers.
ACO-X has a debt to FCF ratio of 27.90. This is a negative value and a sign of low solvency as ACO-X would need 27.90 years to pay back of all of its debts.
ACO-X has a Debt to FCF ratio of 27.90. This is amongst the best in the industry. ACO-X outperforms 100.00% of its industry peers.
ACO-X has a Debt/Equity ratio of 2.64. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ACO-X (2.64) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.77
ROIC/WACC0.74
WACC5.03%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

ACO-X has a Current Ratio of 1.81. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
ACO-X's Current ratio of 1.81 is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
A Quick Ratio of 1.66 indicates that ACO-X should not have too much problems paying its short term obligations.
ACO-X has a better Quick ratio (1.66) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

ACO-X shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.19%, which is quite good.
Measured over the past 5 years, ACO-X shows a small growth in Earnings Per Share. The EPS has been growing by 6.10% on average per year.
ACO-X shows a small growth in Revenue. In the last year, the Revenue has grown by 7.75%.
The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

The Earnings Per Share is expected to grow by 4.92% on average over the next years.
Based on estimates for the next years, ACO-X will show a small growth in Revenue. The Revenue will grow by 0.61% on average per year.
EPS Next Y8.28%
EPS Next 2Y4.17%
EPS Next 3Y4.92%
EPS Next 5YN/A
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.84 indicates a reasonable valuation of ACO-X.
The rest of the industry has a similar Price/Earnings ratio as ACO-X.
ACO-X is valuated cheaply when we compare the Price/Earnings ratio to 26.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.54 indicates a reasonable valuation of ACO-X.
ACO-X's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.40. ACO-X is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.84
Fwd PE 11.54
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACO-X is valued a bit cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ACO-X is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.98
EV/EBITDA 8.22
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.43
PEG (5Y)1.94
EPS Next 2Y4.17%
EPS Next 3Y4.92%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.66%, ACO-X has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.53, ACO-X's dividend is way lower than its industry peers. On top of this 95.00% of the companies listed in the same industry pay a better dividend than ACO-X!
ACO-X's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.66%

5.2 History

The dividend of ACO-X has a limited annual growth rate of 3.93%.
ACO-X has paid a dividend for at least 10 years, which is a reliable track record.
ACO-X has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACO-X pays out 52.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
ACO-X's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.2%
EPS Next 2Y4.17%
EPS Next 3Y4.92%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CLASS I

TSX:ACO-X (12/4/2025, 7:00:00 PM)

53.74

-0.76 (-1.39%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners29.15%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap6.02B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.57
Price Target58.82 (9.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.66%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-Date12-04 2025-12-04 (0.5045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)2.98%
PT rev (3m)3.5%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0.71%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-4.42%
Revenue NY rev (3m)-4.42%
Valuation
Industry RankSector Rank
PE 11.84
Fwd PE 11.54
P/S 1.17
P/FCF 12.98
P/OCF 2.47
P/B 1.27
P/tB 1.78
EV/EBITDA 8.22
EPS(TTM)4.54
EY8.45%
EPS(NY)4.66
Fwd EY8.66%
FCF(TTM)4.14
FCFY7.7%
OCF(TTM)21.76
OCFY40.49%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.43
PEG (5Y)1.94
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.77
F-Score7
WACC5.03%
ROIC/WACC0.74
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y8.28%
EPS Next 2Y4.17%
EPS Next 3Y4.92%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year427.2%
EBIT Next 3Y80.42%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CLASS I / ACO-X.CA FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ACO-X.CA.


Can you provide the valuation status for ATCO LTD -CLASS I?

ChartMill assigns a valuation rating of 5 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Fairly Valued.


How profitable is ATCO LTD -CLASS I (ACO-X.CA) stock?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 4 / 10.


What is the valuation of ATCO LTD -CLASS I based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ATCO LTD -CLASS I (ACO-X.CA) is 11.84 and the Price/Book (PB) ratio is 1.27.


How financially healthy is ATCO LTD -CLASS I?

The financial health rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10.